I SHOULD like to express first of all my appreciation of the honour which has been paid to me by this invitation to deliver the Menary lecture.
I have chosen as the title of my lecture this afternoon the "Congenital Haemolytic Anximias." Let me be honest and admit that this is a thin disguise for a discussion of Cooley's Anamia, a condition in which I have been interested for some years. This interest is not wholly academic. There are 45,000 Cypriots living in London and at times I suspect that they are all living within half a mile of mv Infant Welfare Clinic at The Middlesex Hospital and are regular attenders. This interest in thalassxtmia has therefore rather been thrust upon nme.
It is approximately sixty years since the congenital hxnmolytic anxnmias were first described clinically, but it is only within recent years, however, that we have achieved some knowledge of the basic cell defects which are responsible for the clinical manifestations of these diseases.
This afternoon I should like to discuss three of these congenital or constitutional anaemias: hereditary spherocytosis or acholuric jaundice; sickle cell anamia or drepanocvtic anaemia; and that strangely complex condition which is variously called Cooley's anamia, thalassamia, or Mediterranean anxmia. My intention in discussing the first two conditions is to try and use the knowledge which has been acquired about their causation in an attempt to throw some light on the basic defect in thalassxmia.
The constitutional hamolytic anxmias share many features in common but vet retain certain individual characteristics. There is a marked hereditary factor and often a strong racial tendency. The bone marrow shows marked hyperplasia, and produces defective red cells, often of characteristic type. The survival of the defective red cells is greatly reduced and the increased haemolysis causes variable degrees of jaundice.
The investigation of these anxmias in the past has been based on the clinical features, and the morphological changes seen in the peripheral blood. Family studies have suggested stronglv that the diseases were genetically determined but these studies have been difficult to interpret because of the infinite variations in clinical pattern and behaviour seen in the three anxmias. In recent years the recognition and exclusion of closely allied conditions have made these family studies much easier to interpret.
During the past ten years the discovery of the abnornmal hxmoglobins has afforded a valuable method for the further investigation of the constitutional anamias. The existence of faetal hoemoglobin has been known for almost one hundred years and is sometimes called "resistant" hamoglobin because of the difficulty with which it is denatured by strong alkali compared with adult hxmoglobin. In the normal newborn infant over 80 per cent. of the hxmoglobin is usuallv in the foetal form. After birth the A haemoglobin gene suppresses the activity of the F gene and the percentage of F hamoglobin falls to about 50 per cent. at the age of three months. After this time the foetal hamoglobin disappears rapidly although small amounts persist for many months or even years. Opinions vary as to the level at which this foetal form may persist and figures of from 1-2 per cent. are variously quoted. Higher percentages have been found in patients suffering from haemolytic anaemias, leukxmia, aplastic and pernicious anamia. Fcetal hemoglobin is a naturally occurring form and is not an abnormal haemoglobin although it is usually only found in the young baby.
The Hereditary spherocytosis or acholuric jaundice is a chronic familial anxmia often of slight degree with a variable enlargement of the spleen. There is a mild jaundice without bilirubin being present in the urine, and a great tendenicy to acute crises of hxmolysis with the rapid development of a marked anxmia.
The clinical picture is very often not manifest in early childhood but occasionally svmptoms are present during the earliest days of life. I have seen hxmolytic crises as early as two months of age and splenectomy has been performed as early as the seventeenth day of life. The condition must be borne in mind in the differential diagnosis of neonatal jaundice, although it is not often discovered.
Between crises the general health is usually good with only a slight anxmia, icterus and splenomegaly. The crises often appear to be precipitated by intercurrent infections and the child becomes feverish and ill; there is increased
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jaundice anid enlargement of the spleen; and the hoemoglobin falls rapidly because of the increased hoemolysis. The degree of anxmias thus produced may be severe and require blood transfusion, but the average case requires no specific therapy and the stage of increased hoemolysis lasts onily a week or two.
The hx~matological findings are those of a mild anacimia with a colour index near to unity but with the red cells showing miicrocystosis and spherocytosis.
The white cell count is within normal limits. The peripheral blood between crises shows a constantly increased reticulocyte counit and after a hoemolytic crisis this reticulocytosis may reach 50 per cent. or more, and miacrocytes appear in the peripheral blood. The fragility of the erythrocytes in hypotonic saline is greatly increased and this is very characteristic of the disease, although the finding may be variable.
No abnormal hxmoglobin characteristic of the disease has yet been demonstrated although fretal hxmoglobin is present in excess of normal levels.
Family studies suggest that the transmission of hereditary spherocytosis is by an incompletely or semi-dominant gene. Those who suffer from the disease are probably heterozygous and the true homozygous state is not detectable clinically.
The spherocytes seen in the peripheral blood are thought to be the characteristic cells of the disease and it is believed that they are the result of a defective enzyme system in the cell. It is known that about one-third of the energy output of the red cell is devoted to maintaining potassium in the cell and eliminating sodium. The spherocyte shows potassium depletion and an upset of normal glucose metabolism. There is a defect in the adenosine triphosphate enzyme system in those erythrocytes and therefore a breakdown of the normal glucose metabolism in the spherocyte. In conditions where there is a deficiency of glucose, or competition for glucose, the abnormal cell suffers in comparison with the normal cell, potassium depletion develops, and the cell "spheres" and is liable to destruction. Such conditions are found in the spleen where the red cells normally may be held for four to six hours in high concentration. The available glucose level is low and hamolysis of the spherocytes occurs. For this reason splenectomy in acholuric jaundice is curative in terms of the clinical symptoms although it does nothing to alter the basic defect in the cells.
Acholuric jaundice is therefore a familial and genetically determined anxmia in which the basic defect is probably in an enzyme system within the erythrocytes, not all of whom are affected.
SICKLE (Fig. 3, P1 . I). The fragility of the red cells is not characteristically altered. X-ray of the skeleton may show the changes of marrow hyperplasia.
The sickle trait is said to occur in 5-10 per cent. of North American negroes, but in Africa this proportion varies widely from tribe to tribe, the trait being present in 45 per cent. of some communities. In North American negroes about one in forty of the individuals carrying the trait shows the clinical picture of sickle cell anxmia. In 1949 Neel showed that the condition is genetically determined, the S gene being an allele of the A gene. The heterozygous carrier of the gene shows sicklaxmia and it is only in the homozygous carrier that the fullblown picture of the sickle cell anaemia develops. In the same year Pauling demonstrated that the abnormal hamoglobin S is the outward manifestation of this genetic abnormality. In the heterozygote S haemoglobin is present to the extent of about 22-45 per cent. with the remainder of the haemoglobin as A but in true sickle cell anxmia the patient who is homozygous for the gene shows 80-98 per cent. hxmoglobin S and the remainder 2-20 per cent. F haemoglobin. Thalassemia minor shows a constant mild anxmia of the hypochromic type in which a lack of full hemoglobinisation is compensated by high red cell counts, 69 although the tvpical haematological abnormalities are seen in the blood. Good general health may be enjoyed by these individuals.
Thalassamia major is more usually seen in young children in whom a progressive anaemia develops with splenomegaly of quite marked degree. The anxmia and splenomegaly may develop in the early weeks of life and the earlier the symptoms appear the more rapid is the deterioration. We have seen the condition suspected at the age of three weeks and fully established by the sixth week of life. Hamolytic crises are much less evident than in sickle cell anaemia although intercurrent infections seem to accelerate the rate of fall in the red cell count.
In established cases there is a muddy pallor of the complexion and the veins are abnormally visible. The liver and the spleen are considerably enlarged and are firm. These patients develop a characteristic facies which is described as Mongoloid and it has been said that they more closely resemble each other than they resemble their unaffected brothers and sisters (Figs. 4 and 5, P1 . II). The anxamia is progressive although the rate of progression varies widely from case to case, but few of the patients with severe symptoms live beyond the tenth year. In less severely affected patients the disease appears to slow its progression once the patients pass the age of ten. Death is usually from heart failure caused by the anxmia although intercurrent infections are also important. Hrmosiderosis is comnmon and may partly be due to the repeated transfusions.
Hrematological findings. The red cells show a marked hypochromia and the colour index is low, often 0.6. This feature is in marked distinction to the two other anamias we have discussed. The red cells (Fig. 6, P1 . I) show marked variationi in size and shape and large numbers of macrocytes are seen, large, thin, pancake-like cells poorly filled with haemoglobin and distorted into the target or Mexican hat forms. There are large numbers of fragmented cells in the peripheral blood, and this, together with the high nucleated red cell count, shows the marked degree of red cell destruction which is occurring. The serum is usually definitely icteric. There serum iron is high (ofteni 400 1e) and the iron binding capacity of the serum protein is low. The erythrocyte fragility in hypotonic saline is reduced and the fragility curve is on a wide base. This together with the hypochromic anrmia is characteristic.
There is marked extramedullary hrmatopoiesis and after some time the skeletal X-rays give evidence of this. The marrow spaces are wide and trabeculation is seen. In the skull there may be marked spiculation over the vertex (Fig. 7,  P1. II1 ).
There is no treatment for the disease other than symptomatic. Although the disease is a hypochromic anxmia, iron therapy does nothing to slow the inevitable progression of the anoemia, or to lengthen the interval between the transfusions which become necessarv to maintain life. The inherent defect in hoemoglobin synthesis prevents the use of the available iron. This patient is really living on transfused blood. The place of splenectomy in the disease has been the subject of controversy. In hereditary spherocytosis the cell destruction takes place largely in the spleen and splenectomy effects a clinical cure. In thalassxmia 70 the destruction of the abnormal red cells takes place elsewhere and may indeed take place in the marrow at the time of their formation. We had noticed the conisiderable variation in the size of the spleen before, during and after transfusion in some of the more severe cases requiring transfusion at intervals of a few weeks. This suggested that the spleen might be showing a secondary hypersplenism and negativing the benefit of the transfusions. We have carried out splenectomy in four cases, but, as the slides show, without any convincing evidence that splenectomy has greatly lessened the frequency of need for transfusion (Fig. 8) .
There is, however, some evidence that splenectomy may be beneficial to some degree. It is our impression that the treatment of any chronic focus of infection is of great benefit and in one case tonsillectomy seemed to confer a greater benefit than subsequently did removal of the spleen.
These patients require frequent transfusions and, especially in the younger children, this may create a great technical difficultv over veins. Intraperitoneal transfusion offers great advantages in this type of case. We have had an opportunity of seeing the peritoneal cavity of a child one week after an intraperitoneal transfusion of blood in an amount equal to one-third of the blood volume. At operation the peritoneum looked normal and all the blood had been absorbed. We have transfused blood intraperitoneally on ten occasions in one case, and on eighteen occasions in another patient. Absorption of the transfused blood continues satisfactorily in successive transfusions.
The prognosis in these cases without transfusion is very grave and if tranfusion is required in the first two years of life the prognosis is virtually hopeless. In general, there appears to be an optimum hTmoglobin level at which these patients remain comfortable but above which the hamoglobin level cannot long be retained. It is useless to transfuse above this level. Although it is believed that thalassaemia is genetically transmitted and that thalassoemia minor represents the heterozygote and thalassxemia major the homozygous carrier of the gene, the inheritance is not so clearly defined as in sickle cell anamia. This slide shows 71 the familial nature of the anamia (Fig. 9, P1. IV Another point of interest is the poor haemoglobinisation which occurs even in the presence of high levels of serum iron.
The failure of real benefit from splenectomy suggests that the anamia is due to a central defect and not to a peripheral destruction.
It has been suggested that in thalassxemia there is a marked destruction of red cells in the marrow at the time of formation as if the cells were too defective ever to reach the circulation. Alternatively, it has been suggested that the defect is a failure or inhibition of the A gene. 'The production of F or A2 haemoglobin is, therefore, a compensatory mechanism to h;moglobinize the cells with a less efficient substitute. In thalass-xmia-S syndromes the enhancement of production of S hzmoglobin suggests that this is easier to produce than F. Whichever of these reasons is the true one, it would appear that the basic defect in thalassxmia is genetically determined and that a defective cell is produced, the defect probably being in hemoglobin synthesis without the production of a specific abnormal hemoglobin. 1935 1936 1943 1945 1947 1948 1950 1952 1953 1954 1955 1958 O /\ A AfORPA4L.
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FIG. 9.
The familial inheritance of sickle-cell anamia.
PLATE IV
